Showing 1 - 11 results of 11 for search 'Todd A. DeWees, PhD', query time: 0.04s
Refine Results
-
1
-
2
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy by Fady F. Youssef, MS, Parag J. Parikh, MD, Todd A. DeWees, PhD, Matthew G. Mutch, MD, Benjamin R. Tan Jr. MD, Perry W. Grigsby, MD, Robert J. Myerson, MD, PhD, Jeffrey R. Olsen, MD
Published 2016-04-01
Article -
3
Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus by Michael L. Cardenas, MD, Christopher R. Spencer, MD, MS, Stephanie Markovina, MD, PhD, Todd A. DeWees, PhD, Thomas R. Mazur, PhD, Ashley A. Weiner, MD, Parag J. Parikh, MD, Jeffrey R. Olsen, MD
Published 2017-07-01
Article -
4
Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer by Justin D. Anderson, MD, Molly M. Voss, Brady S. Laughlin, MD, Allison E. Garda, MD, Khaled Aziz, Trey C. Mullikin, MD, Michael G. Haddock, MD, Ivy A. Petersen, MD, Todd A. DeWees, PhD, Sujay A. Vora, MD
Published 2022-11-01
Article -
5
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-R... by Brady S. Laughlin, MD, Cameron S. Thorpe, MD, Todd A. DeWees, PhD, Molly M. Voss, BA, John H. Chang, MD, William F. Hartsell, MD, Christopher C. Sinesi, MD, Jean-Claude M. Rwigema, MD, Sameer R. Keole, MD, Vinai Gondi, MD, Carlos E. Vargas, MD
Published 2023-05-01
Article -
6
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy by Brady S. Laughlin, MD, Molly M. Voss, BA, Diego A.S. Toesca, MD, Thomas Daniels, MD, Michael A. Golafshar, MS, Sameer R. Keole, MD, William W. Wong, MD, Jean-Claude Rwigema, MD, Brian Davis, MD, Steven E. Schild, MD, Brad J. Stish, MD, Richard Choo, MD, Scott Lester, MD, Todd A. DeWees, PhD, Carlos E. Vargas, MD
Published 2023-03-01
Article -
7
Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo C... by Nathan Y. Yu, MD, Todd A. DeWees, PhD, Chenbin Liu, PhD, Thomas B. Daniels, MD, Jonathan B. Ashman, MD, PhD, Staci E. Beamer, MD, Dawn E. Jaroszewski, MD, Helen J. Ross, MD, Harshita R. Paripati, MD, Jean-Claude M. Rwigema, MD, Julia X. Ding, Jie Shan, MS, Wei Liu, PhD, Steven E. Schild, MD, Terence T. Sio, MD, MS
Published 2020-05-01
Article -
8
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery by Cameron S. Thorpe, MD, Todd A. DeWees, PhD, Brady S. Laughlin, MD, Laura A. Vallow, MD, Dee Seneviratne, MD, PhD, Barbara A. Pockaj, MD, Patricia A. Cronin, MD, Michele Y. Halyard, MD, Tamara Z. Vern-Gross, DO, FAAP, Lisa A. McGee, MD, Sarah A. McLaughlin, MD, Molly M. Voss, BA, Michael A. Golafshar, MS, Gabriella F. Bulman, BS, Carlos E. Vargas, MD
Published 2023-01-01
Article -
9
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience by Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD
Published 2021-07-01
Article -
10
Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A... by Ronik S. Bhangoo, MD, Todd A. DeWees, PhD, Nathan Y. Yu, MD, Julia X. Ding, BA, Chenbin Liu, PhD, Michael A. Golafshar, MS, William G. Rule, MD, Sujay A. Vora, MD, Helen J. Ross, MD, Daniel H. Ahn, DO, Staci E. Beamer, MD, Dawn E. Jaroszewski, MD, Christopher L. Hallemeier, MD, Wei Liu, PhD, Jonathan B. Ashman, MD, PhD, Terence T. Sio, MD, MS
Published 2020-09-01
Article -
11
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience by Brady S. Laughlin, MD, Sasha Ebrahimi, MD, PhD, Molly M. Voss, BA, Samir H. Patel, MD, Robert L. Foote, MD, Lisa A. McGee, MD, Joaquin Garcia, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben Wittich, MD, Katharine A. Price, MD, Alessandra Schmitt, MD, Qihui Zhai, MD, Byron C. May, MD, Thomas H. Nagel, MD, Michael L. Hinni, MD, Ashish V. Chintakuntlawar, MBBS, PhD, Todd A. DeWees, PhD, Jean-Claude M. Rwigema, MD
Published 2023-07-01
Article